Hana Pharm Co., Ltd. (KRX:293480)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,760
-250 (-2.27%)
Feb 20, 2026, 3:30 PM KST
Market Cap191.24B +3.6%
Revenue (ttm)139.33B +11.9%
Net Income24.30B
EPS2,243.00
Shares Out17.77M
PE Ratio4.80
Forward PEn/a
Dividend510.00 (4.63%)
Ex-Dividend Daten/a
Volume202,287
Average Volume88,858
Open11,010
Previous Close11,010
Day's Range10,660 - 11,150
52-Week Range10,050 - 12,500
Beta0.27
RSI53.90
Earnings DateNov 14, 2025

About Hana Pharm

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1996
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 293480
Full Company Profile

Financial Performance

Financial Statements